Q3 2024 Earnings Estimate for Keurig Dr Pepper Inc. (NASDAQ:KDP) Issued By Wedbush

Keurig Dr Pepper Inc. (NASDAQ:KDP) – Equities research analysts at Wedbush decreased their Q3 2024 earnings per share (EPS) estimates for Keurig Dr Pepper in a note issued to investors on Friday, April 26th. Wedbush analyst G. Pascarelli now forecasts that the company will post earnings per share of $0.51 for the quarter, down from their previous forecast of $0.52. Wedbush has a “Outperform” rating and a $35.00 price target on the stock. The consensus estimate for Keurig Dr Pepper’s current full-year earnings is $1.91 per share. Wedbush also issued estimates for Keurig Dr Pepper’s Q1 2025 earnings at $0.40 EPS, Q3 2025 earnings at $0.55 EPS, Q4 2025 earnings at $0.64 EPS and FY2025 earnings at $2.07 EPS.

Keurig Dr Pepper (NASDAQ:KDP) last posted its quarterly earnings results on Thursday, April 25th. The company reported $0.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.34 by $0.04. Keurig Dr Pepper had a net margin of 14.52% and a return on equity of 10.18%. The company had revenue of $3.47 billion for the quarter, compared to the consensus estimate of $3.41 billion. During the same period last year, the firm posted $0.34 EPS. The company’s revenue for the quarter was up 3.4% on a year-over-year basis.

Several other analysts also recently issued reports on the company. TD Cowen raised their price target on Keurig Dr Pepper from $32.00 to $35.00 and gave the stock a “hold” rating in a report on Friday. Royal Bank of Canada reduced their price target on shares of Keurig Dr Pepper from $42.00 to $41.00 and set an “outperform” rating for the company in a report on Friday, February 23rd. Jefferies Financial Group lowered their price target on shares of Keurig Dr Pepper from $37.00 to $35.00 and set a “buy” rating for the company in a research report on Wednesday, March 27th. Barclays lifted their price objective on shares of Keurig Dr Pepper from $32.00 to $36.00 and gave the company an “overweight” rating in a research report on Friday, April 12th. Finally, Morgan Stanley dropped their price target on shares of Keurig Dr Pepper from $37.00 to $34.00 and set an “equal weight” rating on the stock in a research note on Monday, February 26th. Five research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $36.45.

Keurig Dr Pepper Stock Performance

Shares of KDP stock opened at $33.72 on Monday. The company has a market cap of $46.79 billion, a P/E ratio of 21.75, a PEG ratio of 2.57 and a beta of 0.66. The business has a 50 day moving average of $30.41 and a two-hundred day moving average of $31.10. Keurig Dr Pepper has a 52 week low of $27.66 and a 52 week high of $34.65. The company has a quick ratio of 0.25, a current ratio of 0.51 and a debt-to-equity ratio of 0.52.

Keurig Dr Pepper Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, April 12th. Stockholders of record on Friday, March 29th were issued a $0.215 dividend. This represents a $0.86 annualized dividend and a dividend yield of 2.55%. The ex-dividend date was Wednesday, March 27th. Keurig Dr Pepper’s dividend payout ratio (DPR) is presently 55.48%.

Insider Activity at Keurig Dr Pepper

In other news, major shareholder Holdings B.V. Jab sold 51,956,522 shares of the business’s stock in a transaction on Tuesday, March 5th. The stock was sold at an average price of $28.90, for a total value of $1,501,543,485.80. Following the sale, the insider now owns 331,487,357 shares of the company’s stock, valued at approximately $9,579,984,617.30. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other news, major shareholder Holdings B.V. Jab sold 51,956,522 shares of Keurig Dr Pepper stock in a transaction that occurred on Tuesday, March 5th. The shares were sold at an average price of $28.90, for a total value of $1,501,543,485.80. Following the transaction, the insider now owns 331,487,357 shares of the company’s stock, valued at approximately $9,579,984,617.30. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Robert S. Singer sold 12,132 shares of the stock in a transaction that occurred on Tuesday, March 5th. The shares were sold at an average price of $29.25, for a total transaction of $354,861.00. Following the sale, the director now directly owns 37,643 shares of the company’s stock, valued at $1,101,057.75. The disclosure for this sale can be found here. Insiders have sold 100,012,132 shares of company stock worth $2,890,354,861 over the last quarter. 0.81% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Keurig Dr Pepper

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Achmea Investment Management B.V. lifted its position in shares of Keurig Dr Pepper by 0.8% in the 3rd quarter. Achmea Investment Management B.V. now owns 38,847 shares of the company’s stock valued at $1,226,000 after acquiring an additional 324 shares in the last quarter. Morningstar Investment Management LLC raised its stake in Keurig Dr Pepper by 1.1% during the 4th quarter. Morningstar Investment Management LLC now owns 31,543 shares of the company’s stock valued at $1,051,000 after purchasing an additional 328 shares during the period. Kentucky Retirement Systems lifted its holdings in shares of Keurig Dr Pepper by 0.4% in the fourth quarter. Kentucky Retirement Systems now owns 80,555 shares of the company’s stock valued at $2,684,000 after purchasing an additional 344 shares in the last quarter. Operose Advisors LLC boosted its position in shares of Keurig Dr Pepper by 28.7% in the third quarter. Operose Advisors LLC now owns 1,673 shares of the company’s stock worth $53,000 after buying an additional 373 shares during the period. Finally, Mckinley Capital Management LLC grew its stake in Keurig Dr Pepper by 1.3% during the 3rd quarter. Mckinley Capital Management LLC now owns 35,749 shares of the company’s stock valued at $1,129,000 after acquiring an additional 470 shares in the last quarter. 85.23% of the stock is owned by institutional investors and hedge funds.

About Keurig Dr Pepper

Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.